Key result
Longitudinal biobank evaluation characterizes genetic HCM penetrance and transition to disease.
Key points are not available for this paper at this time.
Supports refined penetrance estimates for genetic counseling; leaves open broader validation before changing practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2025) studied this question. Genetic hypertrophic cardiomyopathy penetrance and transition to disease were characterized through longitudinal evaluation in an academic biobank.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: